Prognostic model developed for MDS related to prior cancer therapy
Tuesday, December 13, 2011 - 11:03
in Health & Medicine
A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from The University of Texas MD Anderson Cancer Center report at the 53rd Annual Meeting of the American Society of Hematology.